Showing results (1951-1960 of 2,046) with videos related to

Sort By:
Pageof 205
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2024
Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast CancerKomal L Jhaveri, Melissa K Accordino, Philippe L Bedard, et al.
The New England Journal of Medicine|May 31, 2023
Capivasertib in Hormone Receptor-Positive Advanced Breast CancerNicholas C Turner, Mafalda Oliveira, Sacha J Howell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2016
Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancerM Chatterjee, D C Turner, E Felip, et al.
Epidemiology (Cambridge, Mass.)|October 10, 2018
Nonparticipation Selection Bias in the MOBI-Kids StudyMichelle C Turner, Esther Gracia-Lavedan, Franco Momoli, et al.
Plos One|June 19, 2013
Ketamine effects on memory reconsolidation favor a learning model of delusionsPhilip R Corlett, Victoria Cambridge, Jennifer M Gardner, et al.
Open Forum Infectious Diseases|December 18, 2024
In Children, N-Methyl-D-Aspartate Receptor Antibody Encephalitis Incidence Exceeds That of Japanese Encephalitis in VietnamNguyen Hoang Thien Huong, Nguyen Duc Toan, Tran Ba Thien, et al.
The Lancet. Oncology|August 30, 2024
Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trialMafalda Oliveira, Hope S Rugo, Sacha J Howell, et al.
Nature Communications|May 29, 2023
Rapid evolution of A(H5N1) influenza viruses after intercontinental spread to North AmericaAhmed Kandeil, Christopher Patton, Jeremy C Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2023
Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer PatientsJavier Pascual, Miguel Gil-Gil, Paula Proszek, et al.
Journal of Medicinal Chemistry|June 23, 2007
In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 antagonistsRichard J Perner, Stanley DiDomenico, John R Koenig, et al.
Pageof 205